{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:58:16Z","timestamp":1792112296231,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001634","name":"University of Galway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.phrs.2016.08.033","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T21:15:26Z","timestamp":1473110126000},"page":"228-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"PA","title":["Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid"],"prefix":"10.1016","volume":"113","author":[{"given":"Daniel M.","family":"Kerr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Gilmartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.08.033_bib0005","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2016.08.033_bib0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1469-8749.1994.tb11858.x","article-title":"Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs","volume":"36","author":"Christianson","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.phrs.2016.08.033_bib0015","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder","volume":"47","author":"Rasalam","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.phrs.2016.08.033_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism \u2212 a current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.phrs.2016.08.033_bib0025","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","volume":"99","author":"Huang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.08.033_bib0030","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1042\/BST0341095","article-title":"Cannabinoids and PPAR alpha signalling","volume":"34","author":"Sun","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.phrs.2016.08.033_bib0035","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.08.033_bib0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"Overton","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2016.08.033_bib0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuroscience.2011.07.052","article-title":"Cannabinoids and emotionality: a neuroanatomical perspective","volume":"204","author":"McLaughlin","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2016.08.033_bib0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tips.2010.06.008","article-title":"The pleasures of play: pharmacological insights into social reward mechanisms","volume":"31","author":"Trezza","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2016.08.033_bib0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2011.01.044","article-title":"Social encounter with a novel partner in adolescent rats: activation of the central endocannabinoid system","volume":"220","author":"Marco","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2016.08.033_bib0060","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1212\/WNL.57.9.1618","article-title":"Postmortem brain abnormalities of the glutamate neurotransmitter system in autism","volume":"57","author":"Purcell","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2016.08.033_bib0065","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1460-9568.2006.04697.x","article-title":"Variations in the human cannabinoid receptor (CNR1) gene modulate striatal responses to happy faces","volume":"23","author":"Chakrabarti","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2016.08.033_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2040-2392-2-10","article-title":"Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces","volume":"2","author":"Chakrabarti","year":"2011","journal-title":"Mol. Autism"},{"key":"10.1016\/j.phrs.2016.08.033_bib0075","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1111\/ejn.12561","article-title":"Cannabinoid receptor type 1 receptors on GABAergic vs: glutamatergic neurons differentially gate sex-dependent social interest in mice","volume":"40","author":"Terzian","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2016.08.033_bib0080","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1523\/JNEUROSCI.0114-12.2012","article-title":"Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats","volume":"32","author":"Trezza","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.08.033_bib0085","doi-asserted-by":"crossref","first-page":"14084","DOI":"10.1073\/pnas.1509795112","article-title":"Endocannabinoid signaling mediates oxytocin-driven social reward","volume":"112","author":"Wei","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.08.033_bib0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00213-007-1025-3","article-title":"Bidirectional cannabinoid modulation of social behavior in adolescent rats","volume":"197","author":"Trezza","year":"2008","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.phrs.2016.08.033_bib0095","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.pnpbp.2009.06.020","article-title":"Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors","volume":"33","author":"Umathe","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.08.033_bib0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-010-2051-0","article-title":"Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice","volume":"214","author":"Cassano","year":"2011","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.phrs.2016.08.033_bib0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pnpbp.2012.04.011","article-title":"Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice","volume":"38","author":"Gould","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.phrs.2016.08.033_bib0110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157015911795017047","article-title":"Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders","volume":"9","author":"Onaivi","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.phrs.2016.08.033_bib0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5582\/irdr.2014.01024","article-title":"Modeling fragile X syndrome in the Fmr1 knockout mouse","volume":"3","author":"Kazdoba","year":"2014","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.phrs.2016.08.033_bib0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nm.3127","article-title":"Targeting the endocannabinoid system in the treatment of fragile X syndrome","volume":"19","author":"Busquets-Garcia","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.08.033_bib0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbr.2015.05.003","article-title":"Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome","volume":"291","author":"Qin","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2016.08.033_bib0130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbr.2013.04.043","article-title":"Alterations in the endocannabinoid system in the rat valproic acid model of autism","volume":"249","author":"Kerr","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2016.08.033_bib0135","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2174\/138920111798357357","article-title":"The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation","volume":"12","author":"Alvarez-Jaimes","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.phrs.2016.08.033_bib0140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajhg.2014.02.001","article-title":"A higher mutational burden in females supports a female protective model in neurodevelopmental disorders","volume":"94","author":"Jacquemont","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.phrs.2016.08.033_bib0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijdevneu.2014.10.003","article-title":"Embryological exposure to valproic acid disrupts morphology of the deep cerebellar nuclei in a sexually dimorphic way","volume":"40","author":"Mowery","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.phrs.2016.08.033_bib0150","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","article-title":"Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid","volume":"33","author":"Schneider","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2016.08.033_bib0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12035-014-8987-z","article-title":"MeCP2 modulates sex differences in the postsynaptic development of the valproate animal model of autism","volume":"53","author":"Kim","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2016.08.033_bib0160","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/jnc.12147","article-title":"Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder","volume":"124","author":"Kim","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2016.08.033_bib0165","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.phrs.2016.08.033_bib0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2016.08.033_bib0175","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0031-9384(82)90331-6","article-title":"Short-term isolation increases social interactions of male rats: a parametric analysis","volume":"29","author":"Niesink","year":"1982","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2016.08.033_bib0180","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1476-5381.2011.01445.x","article-title":"The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice","volume":"165","author":"Booker","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.08.033_bib0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1194\/jlr.M012153","article-title":"An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase","volume":"52","author":"Long","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.08.033_bib0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.chembiol.2009.02.013","article-title":"Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain","volume":"16","author":"Ahn","year":"2009","journal-title":"Chem. Biol."},{"key":"10.1016\/j.phrs.2016.08.033_bib0195","doi-asserted-by":"crossref","first-page":"e96396","DOI":"10.1371\/journal.pone.0096396","article-title":"Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain","volume":"9","author":"Hama","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.08.033_bib0200","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.neuroscience.2010.10.030","article-title":"Enhanced nociceptive responding in two rat models of depression is associated with alterations in monoamine levels in discrete brain regions","volume":"171","author":"Burke","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2016.08.033_bib0205","doi-asserted-by":"crossref","first-page":"e0116363","DOI":"10.1371\/journal.pone.0116363","article-title":"Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid","volume":"10","author":"Baronio","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.08.033_bib0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S1461145711001714","article-title":"Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid","volume":"16","author":"Kataoka","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.08.033_bib0215","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1254\/jphs.12025SC","article-title":"Effect of prenatal valproic acid exposure on cortical morphology in female mice","volume":"118","author":"Hara","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2016.08.033_bib0220","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.euroneuro.2014.05.009","article-title":"Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats","volume":"24","author":"Manduca","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.08.033_bib0225","doi-asserted-by":"crossref","first-page":"20270","DOI":"10.1073\/pnas.0909411106","article-title":"Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo","volume":"106","author":"Long","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2016.08.033_bib0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.08.033_bib0235","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/jpet.109.164806","article-title":"Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase","volume":"334","author":"Naidu","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.08.033_bib0240","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1124\/jpet.112.191478","article-title":"Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice","volume":"342","author":"Miller","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.08.033_bib0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pbb.2010.12.002","article-title":"Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay","volume":"98","author":"Kinsey","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2016.08.033_bib0250","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pnpbp.2010.11.027","article-title":"Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice","volume":"35","author":"Gomes","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.08.033_bib0255","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/jnr.22580","article-title":"Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex","volume":"89","author":"Zenko","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.phrs.2016.08.033_bib0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2011.09.032","article-title":"Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor","volume":"1","author":"Kerr","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2016.08.033_bib0265","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00213-007-0795-y","article-title":"Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism","volume":"193","author":"Schneider","year":"2007","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.phrs.2016.08.033_bib0270","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/7854_2009_16","article-title":"Cannabinoids and anxiety","volume":"2","author":"Moreira","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.phrs.2016.08.033_bib0275","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuropharm.2007.08.011","article-title":"The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition","volume":"54","author":"Scherma","year":"2008","journal-title":"Neuropharmacology"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816308660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816308660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T04:50:13Z","timestamp":1668747013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816308660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":55,"alternative-id":["S1043661816308660"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.08.033","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}